Latest Antibody Stories
Adds Immuno-Oncology Development Strength to AnaptysBio's Product Pipeline SAN DIEGO, April 6, 2015 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic
TAMPA, Fla., April 1, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.
Scientists at acib develop world's first continuous purification method for valuable drugs.
NORTH CHICAGO, Ill., March 19, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has entered into an exclusive worldwide license agreement with C(2)N Diagnostics, a privately
One human antibody known as BI 655066 is a promising candidate to be used to target the inflammation-causing protein, interleukin-23.
NantCell To Acquire Exclusive Rights to Antibodies Including CAR-TNK(TM) Products and the Checkpoint Inhibitors PD-1 and PD-L1 SAN DIEGO, Mar.
The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014.
SAN DIEGO, Feb. 23, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.
OXFORD, England and SAN JOSE, California, February 23, 2015 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of
- A person in a secondary role, specifically the second most important character (after the protagonist).
More Images (4 images) »